“Useful and very informative.” - Dr. M. Dolle, National Institute of Public Health and The environment, Netherlands.

“The meeting was stimulating as well as encouraging. It was interactive and had breakthrough data that helps us all.” - Dr. Ken Reed, Director of Technology and Business development, Benitec Australia Ltd.

“Attendance was great and contained a broad range of topics within the field.” - Dr. Tod Woolf, CEO, Sequitur, Inc.

“The meeting was very well organized. I liked that many talks were relatively brief, and covered so much ground. An excellent job overall.” - Malorye Branca, Senior Informatics Editor, Bio-ITWorld magazine.

“The presentations in the meeting was at a very high level from both the academic and technological standpoints, because most invited speakers are working at the frontiers in the field of RNAi.” - Dr. Hideo Akashi, Post-doctoral Fellow, The University of Tokyo, Japan.

“Well organized, very information oriented-solving of problems made easier by those presenting.”
- Krista Evans, Senior Associate Scientist, Avalon Pharmaceuticals.

“Opened possibilities for everyone, informative and useful overall.” - Dr. Xinzhong Wang, Biogen.

“Very good meeting, well run and organized with talks from academic and drug company researchers.” - Jane Clarke, Amaxa Biosystems, Inc.

“It was wonderful experience to attend the RNAi-Boston meeting. The number of attendees and quality of presentations are very impressive. “My assessment is that this meeting represents the state-of-art of RNAi development, for both fundamental science and technology advancement”. The spirit and attitude for each player in the field, particularly to industry players are positive and cohesive.” - Dr. Patrick Lu, Founder & Executive VP, Intradigm Corp.

“Since I am a graduate student in academia the meeting was a great way to network with scientists in biotech/pharma and get some insight into the way research is conducted at those institutions. It was also a great surprise to have all of the speakers presentations available in the program book.” - Monica Vella, Graduate Student, Yale University.

“By attending this meeting, I got a good idea of where the field of siRNA is heading in the near future, overall, the conference was interesting and stimulating.” - Jason Hill, Graduate student, Cleveland Clinic Foundation.

“Excellent meeting, good speakers full coverage of subject.” - Ezra Abrams, Director of New Technology, Apogent Discoveries.

“It was a great organizing efforts.” - Dr. Ye Ding- Wodsworth Center, New York State Health Department.

“Organization of secessions and choice of speakers were excellent. I learnt a lot about RNAi and able to establish connections with the leaders in the RNAi field.” - Dr. Narayan K. Bhat- Principal Scientist, SAICFrederick-National Cancer Institute.

“I very much enjoyed attending the RNAi meeting and having the opportunity to be in touch with the experts in this field to learn form their experience in applying RNAi.”
- Dr. Heidi Geise, Genome Therapeutics Corp.

“It was very interesting meeting for me to attend and know the newest situation of advanced technology in RNAi field. Totally, it was very well organized and arranged.” - Takuji Sekine, Nagase & Co., Ltd. Japan.

“This was the best RNAi meeting I went to this year, well organized and stimulating scientific atmosphere.” - Dr. E. Lader, Global Business Manager, Qiagen.